Healio (1/27, Herpen) reported, “States that enacted medical and recreational policies on cannabis did not see significant increases in rates of psychosis-related health outcomes compared with those that did not,” researchers concluded in a study that “examined commercial and Medicare Advantage claims data between 2003 and 2017, to identify more than 63 million beneficiaries at least 16 years of age, from all 50 states and the District of Columbia.” The findings were published online Jan. 25 in JAMA Network Open.
Related Links:
— “Rate of increase low for psychosis-related outcomes in states with cannabis laws “Robert Herpen, Healio, January 27, 2023